echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > Pharmaceutical equipment orders have potential growth needs, companies accelerate capacity expansion

    Pharmaceutical equipment orders have potential growth needs, companies accelerate capacity expansion

    • Last Update: 2021-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [ Market analysis of chemical machinery equipment network ] With the advancement of consistency evaluation, the normalization of centralized procurement, and the impact of the epidemic, pharmaceutical companies are facing increasingly severe challenges in terms of capacity expansion and continuous cost rise, and it is necessary to accelerate the elimination of outdated and obsolete equipment , Introduce or transform and upgrade highly automated and intelligent equipment, so as to achieve the purpose of reducing costs and increasing efficiency.
    Therefore, as the "mother machine" of pharmaceutical production, pharmaceutical equipment will play a vital role in the transformation and upgrading of the pharmaceutical industry, with opportunities and challenges coexisting.
    Chemical machinery and equipment network market analysis chemical machinery and equipment
    The industry is generally optimistic about the development opportunities of the pharmaceutical equipment industry.
    A few days ago, Industrial Securities issued a research report stating that the pharmaceutical equipment market has entered a growth period of overall stability and partial breakthroughs: With the recovery of the upstream pharmaceutical industry, the Chinese pharmaceutical equipment market is expected to reach US$4.
    58 billion in 2025, with a compound growth rate of 8.
    1%; Southwest Securities 5 A research report was released on 24th, saying that my country's pharmaceutical manufacturing industry has opened a new round of fixed asset investment, and the downstream pharmaceutical machinery industry is expected to fully benefit; Guohai Securities released a report on the pharmaceutical equipment industry in mid-May, expressing optimism about the vigorous development prospects of the domestic pharmaceutical equipment industry .

    It is worth mentioning that while the prospects of the pharmaceutical equipment industry are generally optimistic in the industry, there is still a major problem that needs to be seen, that is, while the pharmaceutical equipment companies are welcoming opportunities and gaining order growth, they are also facing their own capacity constraints, Challenges such as fierce market competition.

     

    The author found that recently, when listed pharmaceutical equipment companies disclosed the 2020 annual report and the first quarter report, the company's production capacity has also attracted the attention of institutions and investors.
    Judging from the situation of some pharmaceutical machinery companies that have received research or issued announcements, in order to respond to the increasing demand for potential orders in the domestic and international markets, large pharmaceutical equipment companies have accelerated their production capacity expansion.

     

    For example, Tofflon said in a survey on May 24 that the company currently has sufficient production capacity.
    In 2020, the company has already deployed the company's production capacity.
    It has carried out smart equipment manufacturing science and technology industrial park projects in Dongtai Xinte Industrial Park, Jiangsu Province, and invested in the construction of biopharmaceutical system equipment industrialization projects in Shanghai Jinshan Industrial Zone.
    The total investment of the two projects is expected to be about 850 million yuan.  

      Chutian Technology also announced on April 16 that the company recently bid for land through bidding, auction and listing, and obtained the real estate certificate issued by the Ningxiang City Natural Resources Bureau.
    The plot is adjacent to Chutian Science and Technology Industrial Park in the west and Chuangye Avenue in Ningxiang City in the east, with a transaction value of 34.
    93 million yuan.
    The land acquired this time will be used for the company's future capacity expansion, and the company will plan and construct according to future business development conditions for the company's main business operations.  

      In addition, Canaan Technology disclosed the "Announcement on the Company's Intention to Participate in the Auction for Land Use Rights" on May 12, 2020.
    The announcement stated that the company intends to participate in the bidding for the Yongjia County Gong 202006 State-owned Construction Land Use Rights as the company's future project expansion or Reserve land for new projects to meet the company’s growing demand for orders in the future; on October 22, 2019, Canaan Technology also announced that it will meet the company’s increasing growth in the company’s biologics water equipment and pharmaceutical dispensing system engineering business and smart logistics business sectors.
    The company’s holding subsidiaries, Shanghai Kaixian and Canaan Feiqi, respectively, intend to establish wholly-owned subsidiaries Nanjing Kaixian and Nanjing Qiyun in Gaochun District, Nanjing.  

      Judging from the above-mentioned large-scale pharmaceutical machinery companies' deployment of production capacity, these companies are already making full preparations for accepting new orders and new opportunities.
    The industry believes that, relatively speaking, large pharmaceutical companies tend to have more advantages in capital, technology, resources, etc.
    than small and medium-sized companies, and are expected to obtain opportunities brought by the industry.
    From the perspective of the development trend of the pharmaceutical equipment industry in recent years, companies in the industry are transforming and upgrading from stand-alone machines to overall solutions, from low-end to mid-to-high-end.
    Many large companies continue to increase R&D investment to improve product quality and added value.
    It is also enriching product lines and increasing the proportion of high-end products in the market.  

      Original title: The pharmaceutical equipment industry has a potential growth demand for orders, companies are accelerating the pace of capacity expansion
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.